| Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors A Bamias, E Kastritis, C Bamia, LA Moulopoulos, I Melakopoulos, ... Journal of clinical Oncology 23 (34), 8580-8587, 2005 | 1619 | 2005 |
| Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer A Maraveyas, J Waters, R Roy, D Fyfe, D Propper, F Lofts, J Sgouros, ... European journal of cancer 48 (9), 1283-1292, 2012 | 360 | 2012 |
| Risk of recurrent venous thromboembolism and major hemorrhage in cancer‐associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 … T Hulle, PL Exter, B Planquette, G Meyer, S Soler, M Monreal, D Jiménez, ... Journal of Thrombosis and Haemostasis 14 (1), 105-113, 2016 | 141 | 2016 |
| Efficacy of reduced-intensity chemotherapy with oxaliplatin and capecitabine on quality of life and cancer control among older and frail patients with advanced gastroesophageal … PS Hall, D Swinson, DA Cairns, JS Waters, R Petty, C Allmark, S Ruddock, ... JAMA oncology 7 (6), 869-877, 2021 | 130 | 2021 |
| The Khorana score for prediction of venous thromboembolism in cancer patients: an individual patient data meta‐analysis N van Es, M Ventresca, M Di Nisio, Q Zhou, S Noble, M Crowther, M Briel, ... Journal of Thrombosis and Haemostasis 18 (8), 1940-1951, 2020 | 84 | 2020 |
| The outcome of elderly patients with advanced urothelial carcinoma after platinum-based combination chemotherapy A Bamias, E Efstathiou, LA Moulopoulos, D Gika, G Hamilos, MP Zorzou, ... Annals of oncology 16 (2), 307-313, 2005 | 84 | 2005 |
| The risk of venous thromboembolism associated with peripherally inserted central catheters in ambulant cancer patients D Jones, K Wismayer, G Bozas, J Palmer, M Elliott, A Maraveyas Thrombosis journal 15, 1-6, 2017 | 66 | 2017 |
| Endometrial cancer: what is new in adjuvant and molecularly targeted therapy? F Zagouri, G Bozas, E Kafantari, M Tsiatas, N Nikitas, MA Dimopoulos, ... Obstetrics and gynecology international 2010 (1), 749579, 2010 | 64 | 2010 |
| Clinicopathological features of ovarian carcinosarcomas: a single institution experience MP Zorzou, S Markaki, A Rodolakis, E Kastritis, G Bozas, MA Dimopoulos, ... Gynecologic oncology 96 (1), 136-142, 2005 | 57 | 2005 |
| Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib G Bozas, A Roy, V Ramasamy, A Maraveyas Oncology Research and Treatment 33 (6), 321-323, 2010 | 56 | 2010 |
| The outcome of advanced or recurrent non-squamous carcinoma of the uterine cervix after platinum-based combination chemotherapy E Kastritis, A Bamias, E Efstathiou, D Gika, G Bozas, P Zorzou, K Sarris, ... Gynecologic oncology 99 (2), 376-382, 2005 | 50 | 2005 |
| Developments in the systemic treatment of endometrial cancer G Mountzios, D Pectasides, E Bournakis, E Pectasides, G Bozas, ... Critical reviews in oncology/hematology 79 (3), 278-292, 2011 | 45 | 2011 |
| Brain metastases as isolated site of relapse in patients with epithelial ovarian cancer previously treated with platinum and paclitaxel-based chemotherapy E Kastritis, E Efstathiou, D Gika, G Bozas, V Koutsoukou, C Papadimitriou, ... International Journal of Gynecologic Cancer 16 (3), 2006 | 44 | 2006 |
| The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy E Kastritis, A Bamias, G Bozas, V Koutsoukou, Z Voulgaris, G Vlahos, ... Gynecologic oncology 104 (2), 372-376, 2007 | 40 | 2007 |
| The Incidence of Osteonecrosis of the Jaw (ONJ) in Patients with Multiple Myeloma Who Receive Biphosphonates Depends on the Type of Biphosphonate. MA Dimopoulos, E Kastritis, LA Moulopoulos, I Melakopoulos, ... Blood 106 (11), 637, 2005 | 40 | 2005 |
| Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment E Efstathiou, G Bozas, A Kostakopoulos, E Kastritis, C Deliveliotis, ... Urology 65 (1), 126-130, 2005 | 37 | 2005 |
| Biweekly gemcitabine and cisplatin in platinum-resistant/refractory, paclitaxel-pretreated, ovarian and peritoneal carcinoma G Bozas, A Bamias, V Koutsoukou, E Efstathiou, D Gika, ... Gynecologic oncology 104 (3), 580-585, 2007 | 36 | 2007 |
| Young age is associated with favorable characteristics but is not an independent prognostic factor in patients with epithelial ovarian cancer: a single institution experience G Bozas, MA Dimopoulos, E Kastritis, E Efstathiou, V Koutsoukou, ... Oncology 70 (4), 265-272, 2006 | 35 | 2006 |
| Evaluating prophylactic heparin in ambulatory patients with solid tumours: a systematic review and individual participant data meta-analysis HJ Schünemann, M Ventresca, M Crowther, M Briel, Q Zhou, S Noble, ... The Lancet Haematology 7 (10), e746-e755, 2020 | 33 | 2020 |
| Prognostic and predictive factors in patients with androgen-independent prostate cancer treated with docetaxel and estramustine: a single institution experience A Bamias, G Bozas, N Antoniou, I Poulias, H Katsifotis, A Skolarikos, ... European urology 53 (2), 323-332, 2008 | 28 | 2008 |
